Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Biogen Inc.    BIIB

BIOGEN INC.

(BIIB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Correction to Poor Performance of Health-Care Stocks Article

share with twitter share with LinkedIn share with facebook
07/05/2020 | 04:28pm EDT

A June survey from Bank of America showed that fund managers view permanently high unemployment as one of the biggest risks that markets are facing. "Coronavirus Is No Cure for Health-Care Stocks" at 8:14 a.m. ET, incorrectly said they view permanently high employment as a risk.

 

Stocks mentioned in the article
ChangeLast1st jan.
BANK OF AMERICA CORPORATION 0.98% 25.115 Delayed Quote.-29.36%
BIOGEN INC. 1.39% 278.415 Delayed Quote.-7.43%
GILEAD SCIENCES, INC. 3.29% 71.86 Delayed Quote.7.02%
HCA HEALTHCARE, INC. -0.76% 125.63 Delayed Quote.-14.32%
INOVIO PHARMACEUTICALS, INC. 5.14% 20.38 Delayed Quote.489.09%
MODERNA, INC. 3.82% 76.8544 Delayed Quote.278.83%
PFIZER, INC. -0.34% 38.3695 Delayed Quote.-1.79%
share with twitter share with LinkedIn share with facebook
Latest news on BIOGEN INC.
07/28BIOGEN : Correction to Biogen Better-Than-Expected 2Q Adjusted Profit Article on..
DJ
07/27Biogen to Present Data at Virtual 2020 Alzheimer's Association International ..
AQ
07/24Biogen to Present Data at Virtual 2020 Alzheimer's Association International ..
GL
07/22BIOGEN : Management's Discussion and Analysis of Financial Condition and Results..
AQ
07/22Eisai to present latest data on pipeline assets in the area of alzheimer's di..
AQ
07/22BIOGEN : Plans to Initiate Phase 4 study Evaluating Benefit of SPINRAZA in Patie..
AQ
07/22BIOGEN : lifts full-year profit forecast as Tecfidera boosts quarter
RE
07/22GLOBAL MARKETS LIVE: Snap, Microsoft, Tesla…
07/22BIOGEN : Correction to Biogen Earnings Article
DJ
07/22BIOGEN : Raises 2020 Profit Forecast
DJ
More news
Financials (USD)
Sales 2020 14 015 M - -
Net income 2020 5 361 M - -
Net cash 2020 207 M - -
P/E ratio 2020 8,43x
Yield 2020 -
Capitalization 43 487 M 43 487 M -
EV / Sales 2020 3,09x
EV / Sales 2021 3,06x
Nbr of Employees 7 400
Free-Float 86,2%
Chart BIOGEN INC.
Duration : Period :
Biogen Inc. Technical Analysis Chart | BIIB | US09062X1037 | MarketScreener
Technical analysis trends BIOGEN INC.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 34
Average target price 304,14 $
Last Close Price 274,69 $
Spread / Highest target 41,6%
Spread / Average Target 10,7%
Spread / Lowest Target -17,0%
EPS Revisions
Managers
NameTitle
Michel Vounatsos Chief Executive Officer & Director
Stelios B. Papadopoulos Chairman
Jeffrey D. Capello Chief Financial Officer & Executive Vice President
Alfred W. Sandrock Chief Medical Officer & EVP-Research & Development
Mark Hernon Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
BIOGEN INC.-7.43%43 487
CSL LIMITED0.50%87 881
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.282.80%42 666
SAMSUNG BIOLOGICS CO.,LTD.69.98%40 657
WUXI BIOLOGICS (CAYMAN) INC.64.01%27 951
UCB53.53%24 353